Manager, Biosample Operations

About Kura Oncology Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives. Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit. Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at www.kuraoncology.com.

Kura Oncology

Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.

OncologyPrecision MedicineTargeted TherapeuticsBiomarkersSolid TumorsBlood Cancersand Research and Development

K

kuraoncology.com

201-500 employees

Biotechnology Research

San Diego, California

2014

Public Company

39k LinkedIn followers

Raised $1.2B

• The Manager, Biosample Operations plans, implements, manages and drives biological sample logistics within Kura Oncology Phase I-IV Clinical Trials, working within our Clinical Operations function, under the leadership of the Head of Clinical Operations (or designee) and in collaboration with Clinical Trial Leaders (CTLs) and cross-functional development team.
• The Manager, Biosample Operations advises on and delivers the biosample strategy within clinical program(s) in accordance with the requirements of quality, and ethical and regulatory standards, including ICH/GCP/GLP.
• Ensures standardization and harmonization of biosample activities across clinical trials and oversight of sample collection, processing, storage, and reconciliation, maximizing biosample sample accrual and quality.
• Review clinical study protocols, informed consents, laboratory documents, case report forms, and service provider laboratory scope of work documents for sample handling details.
• Responsible for ensuring ethical use of biosamples collected in Kura Oncology clinical trials.
• Accountable for planning, coordinating, and overseeing all operational activities required to manage the lifecycle of patient samples (oversight of sample collection at site, shipment to vendor for testing/processing, analysis and final sample disposition)
• Ensures project level consistency occurs for biosampling across studies and is the primary point of contact for project, clinical, and study teams; contributing to innovation and improvement activities in collection, processing and data delivery.
• Track and report on biosample management status/progress, address issues, and resolutions.
• Collaborate with internal and external team members
• Complete other duties as assigned by the manager.
• Bachelor’s degree in science/healthcare field, a nursing degree, or equivalent combined education.
• A minimum of 4-6 years of clinical trial management experience preferred.
• 2+ years of strong hands-on experience in clinical biosample project management preferred.
• Must understand the drug development process in order to effectively manage internal and external cross-functional teams.
• Proven ability to build strong relationships with external partners, CROs, and biosample vendors
• In-depth, working knowledge of Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines.
• Knowledge of regulations and requirements for clinical trial authorization and tissue storage and transfer in major countries.
• Project management skills with ability to identify risks and issues, and propose appropriate measures as required
• Ability to work independently and collaboratively in a fast-paced, matrixed, team environment consisting of internal and external team members.
• Analytical thinker with problem-solving skills and the ability to adapt to changing priorities and deadlines.
• Excellent verbal and written communication skills.
• Planning, organization and time management skills including the ability to support and prioritize multiple projects.
• Accountable for executing decisions made within the function.
• Collaborates with cross-functional partners as needed to support team objectives and ensure alignment with broader program activities.
• Flexibility to travel domestically and internationally as required (~10%).
• Experience with Investigational New Drug applications (INDs) and New Drug Applications (NDAs) submissions, EU and Asia filing experience a plus.
• The base range for this role at the Manager level is $150,000 - $178,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
• Kura’s Values that are used for candidate selection and performance assessments
• We work as one for patients
• We are goal-focused and deliver with excellence
• We are science-driven courageous innovators
• We strive to bring out the best in each other and ourselves
• Career advancement/ development opportunities
• Competitive comp package
• 401K + Employer contributions
• Generous stock options
• 20 days of PTO to start
• Generous Benefits Package with a variety of plans available with a substantial employer match
• In-Office Catered lunches
• Home Office Setup
• Lifestyle Spending Stipend
• Commuter Stipend (Boston Office)
• Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
• Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives.
• Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit.
• Kura developed and is commercializing KOMZIFTI® (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

• 401k
• Employer contributions
• Stock options
• ESPP plan
• Paid time off
• Paid paternity leave
• Paid maternity leave
• Catered lunches
• Home office setup
• Lifestyle spending stipend
• Commuter stipend
• Health insurance